Y-mAbs Therapeutics YMAB
$ 10.38
2.72%
Quarterly report 2024-Q3
added 11-08-2024
Y-mAbs Therapeutics Cash Flow 2011-2024 | YMAB
Annual Cash Flow Y-mAbs Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-27.2 M | -75.9 M | -103 M | -91.2 M | -73.5 M | -41.2 M | -15.9 M | - | - | - | - | - | - |
Depreciation & Amortization |
735 K | 839 K | 782 K | 396 K | 166 K | 29 K | - | - | - | - | - | - | - |
Accounts Payables |
6.06 M | 14.2 M | 13.6 M | 9.37 M | 8.52 M | 5.87 M | - | - | - | - | - | - | - |
Accounts Receivables |
22.5 M | 12.5 M | 7.71 M | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
5.06 M | 6.7 M | 5.51 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Y-mAbs Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -3.48 M | - | - | - | -13.1 M | - | -67.3 M | - | -24.9 M | - | -68.7 M | - | -31.9 M | - | -73.5 M | -49.4 M | -21.8 M | - | -48.9 M | -27.5 M | -13.5 M | - | -27.7 M | -18.5 M | -6.61 M | - | -9.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 159 K | - | - | - | 182 K | - | 609 K | - | 195 K | - | 491 K | - | 130 K | - | 279 K | 186 K | 86 K | - | 87 K | 39 K | 19 K | - | 15 K | 6 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
7.88 M | 10.2 M | 6.73 M | 6.06 M | 7.61 M | 7.25 M | 8.84 M | 14.2 M | 13.7 M | 11.3 M | 14.7 M | 13.6 M | 11 M | 6.8 M | 6.54 M | 9.37 M | 9.37 M | 9.37 M | 9.37 M | 8.52 M | 8.52 M | 8.52 M | 8.52 M | 5.87 M | 5.87 M | 5.87 M | 5.87 M | 5.91 M | 5.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
19.9 M | 22.2 M | 20.6 M | 22.5 M | 18.9 M | 19.1 M | 18.7 M | 12.5 M | 9.25 M | 7.21 M | 9.32 M | 7.71 M | 7.26 M | 8.52 M | 6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
9.56 M | 8.5 M | 8.45 M | 5.06 M | 7.11 M | 5.19 M | 8.94 M | 6.7 M | 6.24 M | 6.79 M | 5.59 M | 5.51 M | 4.79 M | 3.82 M | 1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency